LONZA WALKERSVILLE, INC is associated with UEI LEEXJC9L4NF5 and CAGE 0BCV0 in public federal records. AcornBids currently links 31 prime awards totaling $703.6K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as In-Vitro Diagnostic Substance Manufacturing; Analytical Laboratory Instrument Manufacturing; Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists WALKERSVILLE, MD, USA.
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Public SAM.gov registration details.
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75F40126P00307EO14398; LONZA 4D NUCLEOFECTION SYSTEM | Department of Health and Human Services | $24.3K | Sep 8, 2026 | Jan 8, 2027 |
| 75F40126P00183EO14398; LONZA 4D NUCLEOFECTION SYSTEM | Department of Health and Human Services | $0 | Aug 17, 2026 | Sep 3, 2026 |
| 75F40123P00397TO DETERMINE IF THE PRESENTED PEPTIDES HAVE THE POTENTIAL OF ELICITING AN IMMUNE RESPONSE BY ACTIVATING CD4+ T CELLS. | Department of Health and Human Services | $0 | Sep 28, 2023 | Sep 29, 2024 |
| 75N98026P01166NIAID: SUPPLY: LONZA 4D-NUCLEOFECTOR CORE UNIT, X UNIT, AND ASSOCIATED WARRANTY EXTENSIONS: N/A | Department of Health and Human Services | $26.1K | Aug 3, 2026 | Nov 3, 2026 |
| 75N94021P00489THIS FIRM FIXED PRICE PURCHASE ORDER IS AWARDED FOR 4D-NUCLEOFECTOR CORE UNIT AND RELATED PARTS TO LONZA WALKERSVILLE, INC.:1110291 IN THE AMOUNT OF $19,129.25. QUOTE# 20133944 / 3 | Department of Health and Human Services | $19.1K | Jun 25, 2021 | Sep 30, 2021 |
| 75N91021P00440SCIENTIFIC EQUIPMENT | Department of Health and Human Services | $0 | May 10, 2021 | Aug 2, 2021 |
| 75N91021P00427SCIENTIFIC LABORATORY EQUIPMENT | Department of Health and Human Services | $18.7K | Jun 8, 2021 | Jul 23, 2021 |
| 75N90020P00505FOR REAGENTS SUPPLIES SUPPORT SERVICES. | Department of Health and Human Services | $30.0K | Jun 19, 2020 | May 2, 2026 |
| 75N98026P002014D-NUCLEOFECTOR CORE UNIT AND X UNIT | Department of Health and Human Services | $19.3K | Mar 31, 2026 | Mar 30, 2027 |
| 75N93021P01308LONZA WALKERSVILLE, INC. (AMBIS #2083708)4D -NUCLEOFECTOR | Department of Health and Human Services | $17.8K | Sep 1, 2021 | Sep 17, 2021 |
Modeled recompete windows are estimates, not announced solicitations or guarantees.
| Registration evidence | Date |
|---|---|
| SAM updated | Jan 27, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Jan 28, 2002 |
| Entity start | Nov 1, 1991 |
| Industry | Reported size status |
|---|---|
| 325413 — In-Vitro Diagnostic Substance Manufacturing | Not reported |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| 541990 — All Other Professional, Scientific, and Technical Services | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| EDWARD J PAVINA | Government business | Contact method not published | SAM registration | Not available |
| CHRISTIAN MALDONADO | Electronic business | Contact method not published | SAM registration | Not available |
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Explore the customer, work and award-size evidence behind each match.
Recorded award industries: 325413 — In-Vitro Diagnostic Substance Manufacturing; 334516 — Analytical Laboratory Instrument Manufacturing; 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Recorded products and services: 6640 — Laboratory Equipment and Supplies; 6505 — Drugs and Biologicals; AJ12 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH.
Examples from recent award records:
These records describe federal award work, not every company capability. Review the award evidence.
8830 BIGGS FORD RD, WALKERSVILLE, Maryland 21793, United States
Registered location from SAM.gov; award performance locations may differ.
541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Primary SAM.gov NAICS classification.
Department of Health and Human Services; Department of Veterans Affairs; Department of Agriculture.
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit